NeuroVive: NeuroVive Pharmaceutical AB Establishes China Business
Lund, Sweden, 15 December 2011
Press releases
NeuroVive: NeuroVive and to-BBB awarded Eurostars grant for development of stroke therapy
Lund, Sweden / Leiden, the Netherlands, 29 September 2011 NeuroVive Pharmaceutical AB (publ) and to-BBB, the Dutch brain drug delivery company, have been awarded a grant of €1 million through the Eure ...
NeuroVive: Selcia and NeuroVive to develop new mitochondrial medicines for chronic and acute diseases
Ongar (UK) and Lund (Sweden), September 19, 2011 - UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB (publ) have signed a signific ...
NeuroVive: “TBI Miracle Drug” profiled in US pharmaceutical magazine
Lund, Sweden - September 15, 2011 - A U.S. magazine called Pharmaceutical Formulation & Quality (circulation to 20,000 senior pharmaceutical executives throughout the US and Canada) has just published ...
NeuroVive: First Heart Attack Patient Treated in European Cardioprotection Phase III trial with NeuroVive’s CicloMulsion
Investigator-initiated European multicenter trial of 1,000 acute heart attack patients will examine the ability of cyclosporine to protect cardiac tissue
NeuroVive: NeuroVive and the European Brain Injury Consortium Sign TBI Clinical Trial Collaboration
Note: This is an English version of a press release communicated by NeuroVive 2011-03-02 Phase II/III study will determine the safety and efficacy of NeuroSTAT® in patients with moderate to severe tra ...